1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
(
- Contribution to journal › Article
- 2014
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action.
(
- Contribution to journal › Article
- 2011
-
Mark
Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
(
- Contribution to journal › Article
- 2010
-
Mark
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
(
- Contribution to journal › Article